Autonomix Medical, Inc.
Financial highlights
| Metric | FY March 31, 2026 | FY March 31, 2025 | FY March 31, 2024 | FY March 31, 2023 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating income | -$17.0M | -$11.6M | -$12.0M | -$2.0M |
| Operating expenses | $17.0M | $11.6M | $12.0M | $2.0M |
| Cash from operations | -$12.3M | -$8.3M | -$6.6M | -$1.9M |
| Capital expenditure | $10,000 | $14,000 | $19,000 | $0 |
| Free cash flow | -$12.3M | -$8.3M | -$6.6M | -$1.9M |
| Total assets | $7.6M | $9.8M | $9.4M | $865,000 |
| Total liabilities | $1.7M | $1.7M | $1.8M | $221,000 |
Shares outstanding 11.4M · Free float 49.5%
Annual filing data through FY ended March 31, 2026; float as of June 27, 2026.